FDA Inspection 1113866 — C Randolph Hubbard MD
The FDA completed an inspection of C Randolph Hubbard MD on December 12, 2019 in Lemoyne, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 12, 2019
- Fiscal Year
- 2020
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Lemoyne, PA (United States)
Additional Details
Clinical Investigator (CI)